Dual Targeting of Sorafenib-Resistant HCC-Derived Cancer Stem Cells

Shrestha, R; Bridle, KR; Cao, L; Crawford, DHG; Jayachandran, A

Jayachandran, A (corresponding author), Univ Queensland, Fac Med, Brisbane, Qld 4120, Australia.; Jayachandran, A (corresponding author), Greenslopes Private Hosp, Gallipoli Med Res Inst, Brisbane, Qld 4120, Australia.; Jayachandran, A (corresponding author), Fiona Elsey Canc Res Inst, Ballarat, Vic 3350, Australia.

CURRENT ONCOLOGY, 2021; 28 (3): 2150

Abstract

Sorafenib, an oral multi-tyrosine kinase inhibitor, has been the first-line therapy for the treatment of patients with advanced HCC, providing a survi......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索